Passages reproduced word for word from two earlier-published U.S. patent documents, placed beside the language of claim 1. No characterization is offered. Each passage is marked A or B for the document it comes from; ¶ numbers are the paragraph numbers in the USPTO’s published full text of that document.
Claim 1
Document A
Document B
1.1Ra1, Ra2, and Ra are each independently selected from hydrogen, halogen, hydroxyl, C1-C5 alkyl, C1-C5 alkoxy, C3-C6 cycloalkyl, C3-C6 cycloalkoxy, or —N(Rc3Rc4)m, or any adjacent two of Ra1, Ra2, and Ra3 are linked together to form a 5- to 7-membered ring, the 5- to 7-membered ring is a saturated or unsaturated carbocyclic or heterocyclic ring
Substituents for aryl and heteroaryl are selected from C1-6 alkyl (e.g. methyl), C2-6 alkenyl (e.g. buten-3-yl), C2-6 alkynyl (e.g. butyn-3-yl), C1-6 haloalkyl (e.g. fluoromethyl, trifluoromethyl), —C1-6 thioalkyl (e.g. —S-methyl), —SOC1-4 alkyl (e.g. —SOmethyl), —SO2C1-4 alkyl (e.g. —SO2methyl), C1-6 alkoxy-(e.g. methoxy, ethoxy), —O—C3-8 cycloalkyl (e.g. —O-cyclopentyl or —O-cyclohexyl), C3-8 cycloalkyl (e.g. cyclopropyl, cyclohexyl), —SO2C3-8 cycloalkyl (e.g. —SO2cyclohexy
A · US 11,339,152 B2 · ¶ 82or, any two adjacent or non-adjacent R3 are connected to form a cycloalkyl, heterocyclyl, aryl or heteroaryl, wherein the cycloalkyl, heterocyclyl, aryl and heteroaryl are optionally further substituted by one or more substituents selected from hydrogen, deuterium, substituted or unsubstituted alkyl, substituted or unsubstituted deuterated alkyl, substituted or unsubstituted haloalkyl, substituted or unsubstituted alkoxy, substituted or unsubstituted haloalkoxy, halogen, amin
B · US 2022/0259201 A1 · ¶ 171.2the heterocyclic ring optionally contains one or more N, O, or S(═O)m heteroatoms
The expression “heterocyclyl”, unless specifically limited, refers to a carbocyclyl group wherein one or more (e.g. 1, 2 or 3) ring atoms are replaced by heteroatoms selected from N, S and O. A specific example of a heterocyclyl group is a cycloalkyl group (e.g. cyclopentyl or more particularly cyclohexyl) wherein one or more (e.g. 1, 2 or 3, particularly 1 or 2, especially 1) ring atoms are replaced by heteroatoms selected from N, S or O.
A · US 11,339,152 B2 · ¶ 33The term “heterocyclyl” refers to saturated or partially unsaturated monocyclic or polycyclic hydrocarbon substituent comprising 3 to 20 ring atoms, wherein one or more of the ring atoms are heteroatoms selected from nitrogen, oxygen, C(O), S(O)(═NH) or S(O)m (wherein m is an integer of 0 to 2), but not including the ring part of —O—O—, —O—S— or —S—S—, and the remaining ring atoms are carbon.
B · US 2022/0259201 A1 · ¶ 2741.3Rb1, Rb2, Rb3, and Rb4 are each independently selected from hydrogen, halogen, hydroxyl, C1-C5 alkyl, or C1-C5 alkoxy
Specific substituents that may be mentioned are one or more e.g. 1, 2 or 3 groups selected from halogen, hydroxyl, alkyl (e.g. methyl) and alkoxy-(e.g. methoxy-).
A · US 11,339,152 B2 · ¶ 84Raa, Rbb, Rcc, Rdd and Ree are each independently selected from hydrogen, deuterium, alkyl, deuterated alkyl, haloalkyl, alkoxy, haloalkoxy, halogen, cyano, nitro, hydroxyl, amino, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl or heteroaryl, wherein the alkyl, deuterated alkyl, haloalkyl, alkoxy, haloalkoxy, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl and heteroaryl are optionally further substituted by one or more substituents selected from hydrogen, deuterium, subst
B · US 2022/0259201 A1 · ¶ 201.4or any two of Rb1, Rb2, Rb3, and Rb4 are linked together to form a 3- to 7-membered ring
or, any two of Raa, Rbb and Rcc are optionally connected to form a C3-8 cycloalkyl or a 3-12 membered heterocyclyl, wherein the C3-8 cycloalkyl and 3-12 membered heterocyclyl are optionally further substituted by one or more substituents selected from hydrogen, amino, halogen, cyano, hydroxyl, oxo, imino, C1-6 alkyl or C1-6 hydroxyalkyl;
B · US 2022/0259201 A1 · ¶ 1331.5M1 and M2 are each independently selected from C, O, S(═O)m, or N—Rn, where Rn is optionally selected from hydrogen or C1-C5 alkyl
Y1, Y2, Y3 and Y4 are independently selected from CH, N, S and O;
A · US 11,339,152 B2 · claim 31.6a ring A is A1 or A2: optionally represents a single bond or a double bond
1.7X1, X2, X3, X4, and X5 are each independently selected from a bond, C, N, O, C═O, or S(═O)m
A compound represented by general formula (I), a stereoisomer thereof or a pharmaceutically acceptable salt thereof: wherein: X1-X6 are each independently selected from C, N, CR5, CRaaRbb or NRaa;
B · US 2022/0259201 A1 · claim 11.8Y1 and Y2 are the same or different, and are each optionally selected from a C atom or a N atom
1.9Rc1 and Rc2 are each independently selected from hydrogen, halogen, cyano, hydroxyl, amino, C1-C5 alkyl, C1-C5 alkoxy, —S(═O)m—Rc3Rc4, —C(═O)—NRc3Rc4, —C(═S)—NRc3Rc4, —N(Rc3Rc4)m, —P(═O)m—Rc3Rc4, —C(═N)—NRc3Rc4, —S(═O)2NRc3Rc4, —C1-C5 alkyl NRc3Rc4, or —S(═O)(═NRc3)Rc4
D is selected from aryl-amino, heteroaryl-amino, cycloalkyl-amino, heterocyclyl, heterocyclyl-amino, urea, thioamide, thiourea, sulfonamide and sulfoximine, wherein said aryl, heteroaryl, cycloalkyl and heterocyclyl groups may independently be substituted with one or more substituents;
A · US 11,339,152 B2 · ¶ 66R1 is selected from hydrogen, deuterium, alkyl, deuterated alkyl, haloalkyl, alkoxy, haloalkoxy, halogen, amino, nitro, hydroxyl, cyano, oxo, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, heteroaryl, —(CH2)n1Raa, —(C≡C)n1(CRaaRbb)mRcc, —(C═C)n1(CRaaRbb)mRcc, —(CH2)n1O(CH2)n2(CRaaRbb)mRcc, —(CH2)n1O(CH2)n2Raa, —(CH2)n1S(CH2)n2(CRaaRbb)mRcc, —(CH2)n1O(CH2)n2S(O)mRaa, —(CH2)n1O(CH2)n2S(O)(═NRaa)(CH2)mRbb, —(CH2)n1C(O)Raa, —(CH2)n1C(O)ORaa, —(CH2)n1S(O)mRaa, —(CH2)n1S(O)(═NRa
B · US 2022/0259201 A1 · claim 11.10Rc3 and Rc4 are each independently selected from hydrogen, hydroxyl, amino, C1-C5 alkyl, C1-C5 alkoxy, or a 3- to 7-membered ring, or Rc3 and Rc4 are linked together to form a 3- to 7-membered ring
In a further preferred embodiment, when D is one of the above groups, R forms together with the nitrogen, to which it is attached, a heterocyclic ring of group B. More preferably, said heterocyclic ring, which is formed by the NR group, is selected from piperidine, pyrrolidine, tetrahydrofuran, morpholine, piperazine, dioxolane and dioxane.
A · US 11,339,152 B2 · ¶ 127Raa, Rbb and Rcc, are each independently selected from hydrogen, deuterium, cyano, amino, C1-6 alkyl, C1-6 alkoxy, C1-6 hydroxyalkyl, hydroxyl, C3-8 cycloalkyl, 3-12 membered heterocyclyl or C6-14 aryl, wherein the C1-6 alkyl, C1-6 alkoxy, C1-6 hydroxyalkyl, hydroxyl, C3-8 cycloalkyl, 3-12 membered heterocylcyl and C6-14 aryl are optionally further substituted by one or more substituents selected from hydrogen, halogen, cyano, hydroxyl, oxo, imino, C1-6 alkyl or C1-6 hydroxya
B · US 2022/0259201 A1 · ¶ 1321.11m and n are each optionally 0, 1, or 2
1.12the alkyl, alkoxy, cycloalkyl, cycloalkoxy, 5- to 7-membered ring, or 3- to 7-membered ring is optionally substituted with one or more deuterium, halogen, hydroxyl, cyano, oxo, C1-C5 alkyl, C1-C5 alkoxy, or amino.
When E represents optionally substituted heteroaryl, examples include pyridinyl (e.g. pyridin-2-yl and pyridin-4-yl) and pyrimidinyl. Specific substituents that may be mentioned are one or more e.g. 1, 2 or 3 groups selected from halogen, hydroxyl, alkyl (e.g. methyl) and alkoxy-(e.g. methoxy-).
A · US 11,339,152 B2 · ¶ 84An empty cell means only that no passage was reproduced there.